Cure SMA is thrilled to welcome Biogen back as a National Premier Partner for 2017. The National Premier Partnership represents the highest level of support for the SMA community.
As part of their partnership, Biogen will be sponsoring all walk-n-rolls, golf events, galas and awareness events across the US for the entirety of 2017. Biogen is also a key participant in many of Cure SMA’s ongoing programs, including the SMA Industry Collaboration, supporting events like last month’s Patient-Focused Drug Development Meeting with the FDA, and the SMA Newborn Screening Coalition.
Finally, Biogen will once again be part of the Annual SMA Conference as the 2017 Presenting Sponsor. Biogen is also providing support for the Saturday evening event in Magic Kingdom Park.
“Biogen’s support is absolutely critical to so many of our efforts,” said Kenneth Hobby, president of Cure SMA. “We all celebrated the approval of Spinraza late last year—a milestone our community has been working so many years for, that would not have been possible without Biogen’s tenacious commitment to producing the robust data that led to a broad label approval. And Biogen’s dedication to our community continues, with their support of many of the new initiatives we’ve launched to help maximize our impact in this critical time, as well as support for longstanding events like the Annual SMA Conference.”
In December 2016, the FDA announced that it had approved Spinraza, the first-ever approved therapy to treat SMA. To learn more about the approval of Spinraza, visit www.Spinraza.com or www.cureSMA.org/spinraza.
On behalf of the entire community, we thank Biogen for their tremendous generosity!